Obesity is now a global health hazard. It not only predisposes to an array of risk factors leading to increased morbidity and mortality amongst adults but it also has a major negative impact on children’s health. The deleterious effects of obesity on cardiovascular system have now been well acknowledged. It causes insulin resistance that in turn leads to diabetes, hypertension and cardiovascular abnormalities. The vascular effects of obesity may have a role in the development of a rapidly growing disease of late life, Alzheimer’s disease. The precise mechanisms of the association between adiposity and impairment of cognitive performance remain to be elucidated. However, negative impact of obesity on cognitive function may be, at least in part, due to vascular defects, impaired insulin metabolism and signaling pathway or a defect in glucose transport mechanisms in brain. This review examines the available data regarding the impact of obesity on cognitive function.
Wing RR, Mathews KA, Kuller LH, Meilahn EN, Plantinga P.Waist to hip ratio in middle-aged women. Associations with behavioral and psychological factors and with changes in cardiovascular risk factors. Arterioscler Thromb. 1991;11(5):1250-1257.
2.
Wellman NS, Friedberg B.Causes and consequences of adult obesity: health, social and economic impacts in the United States. Asia Pac J Clin Nutr. 2002;11(suppl 8): S705-S709.
3.
Law CM, Shiell AW, Newsome CA, et al. Fetal, infant and childhood growth and adult blood pressure: a longitudinal study from birth to 22 years of age. Circulation . 2002;105(9):1088-1092.
4.
Lloyd LJ, Langley-Evans SC, McMullen S.Childhood obesity and adult cardiovascular disease risk: a systematic review . Int J Obes. (Lond). 2009May 12. [Epub ahead of print].
5.
Whitaker RC, Wright JA, Pepe MS, Seidel KD, Dietz WHPredicting obesity in young adulthood from childhood and parental obesity . N Engl J Med. 1997;337(13):869-873.
6.
Duflou J., Virmani R., Robin I., Burke A., Farb A., Smialek J.Sudden death as a result of heart disease in morbid obesity. Am J Heart. 1995;130(2):306-313.
7.
Creager MA, Cooke JP, Mendelsohn ME, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86(1):228-234.
8.
Fatani S., Pickavance LC, Sadler CJ, et al. Differential vascular dysfunction in response to diets of differing macronutrient composition: a phenomenonological study. Nutr Metab. (Lond). 2007;4:15.
9.
Naderali EK, Fatani S.The effects of fenofibrate on metabolic and vascular changes induced by chocolate-supplemented diet in the rat. Eur J Pharmacol. 2005;521(1-3):99-104.
10.
Steinberg HO , Chacker H., Leaming R., Johnson A., Brechtel G., Baron ADObesity/insulin resistance is associated with endothelial dysfunction: implications for the syndrome of insulin resistance . J Clin Invest. 1996; 97(11):2601-2610.
11.
Watson GS, Craft S.Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer’s disease. Eur J Pharmacol. 2004;490(1-3):97-113.
12.
Watson GS, Craft S.The role of insulin resistance in the pathogenesis of Alzheimer’s disease: implications for treatment. CNS Drugs. 2003 ;17(1):27-45.
13.
Marks DR, Tucker K., Cavallin MA, Mast TG, Fadool DAAwake intranasal insulin delivery modifies protein complexes and alters memory, anxiety, and olfactory behaviors. J Neurosci. 2009;29(20):6734-6751.
14.
Selkoe DJThe genetics and molecular pathology of Alzheimer’s disease: roles of amyloid and the presenilins. Neurol Clin. 2000;18(4):903-922.
15.
Jellinger KA , Attems J.Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease. Acta Neuropathol . 2007;113(2):107-117.
16.
Premkumar DR , Cohen DL, Hedera P., Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol. 1996 ;148(6):2083-2095.
17.
Profenno LA , Faraone SVDiabetes and overweight associate with non-APOE4 genotype in an Alzheimer’s disease population. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(6):822-829.
18.
Lafortuna CL , Agosti F., Proietti M., Adorni F., Sartorio A.The combined effect of adiposity, fat distribution and age on cardiovascular risk factors and motor disability in a cohort of obese women (aged 18-83). J Endocrinol Invest. 2006;29(10):905-912.
19.
Elias MF, Elias PK, Sullivan LM, Wolf PA, D’Agostino RBLower cognitive function in the presence of obesity and hypertension: the Framingham heart study. Int J Obes Relat Metab Disord. 2003;27(2):260-268.
20.
Fitzpatrick AL, Kuller LH, Lopez OL, et al. Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol.2009;66(3):336-342.
21.
Hughes TF, Borenstein AR, Schofield E., Wu Y., Larson EBAssociation between late-life body mass index and dementia: the Kame Project . Neurology. 2009;72(20):1741-1746.
22.
Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J., Yaffe K.Body mass index in midlife and risk of Alzheimer disease and vascular dementia . Curr Alzheimer Res. 2007;4(2):103-109.
23.
Gunstad J., Paul RH, Cohen RA, Tate DF, Spitznagel MB, Gordon E.Elevated body mass index is associated with executive dysfunction in otherwise healthy adults. Compr Psychiatry. 2007;48(1):57-61.
24.
Gustafson D. , Rothenberg E., Blennow K., Steen B., Skoog I.An 18-year follow-up of overweight and risk of Alzheimer disease. Arch Intern Med. 2003 ;163(13):1524-1528.
25.
Gazdzinski S., Kornak J., Weiner MW, Meyerhoff DJBody mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol. 2008;63(5): 652-657.
26.
Gunstad J., Spitznagel MB, Glickman E., et al. beta-Amyloid is associated with reduced cognitive function in healthy older adults. J Neuropsychiatry Clin Neurosci. 2008;20(3):327-330.
27.
Leahey TM, Myers TA, Gunstad J., et al. Abeta40 is associated with cognitive function, body fat and physical fitness in healthy older adults. Nutr Neurosci. 2007;10(5-6): 205-209.
Moroz N., Tong M., Longato L., Xu H., de la Monte SMLimited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus. J Alzheimers Dis. 2008 ;15(1):29-44.
30.
Gustafson D. , Lissner L., Bengtsson C., Björkelund C., Skoog I.A 24-year follow-up of body mass index and cerebral atrophy. Neurology. 2004;63(10): 1876-1881.
31.
Cao D., Lu H., Lewis TL, Li L.Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease . J Biol Chem. 2007;282(50):36275-36282.
